200 related articles for article (PubMed ID: 27084617)
1. Establishing Cost-Effective Allocation of Proton Therapy for Breast Irradiation.
Mailhot Vega RB; Ishaq O; Raldow A; Perez CA; Jimenez R; Scherrer-Crosbie M; Bussiere M; Taghian A; Sher DJ; MacDonald SM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):11-18. PubMed ID: 27084617
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
3. Establishing Cost-Effective Allocation of Proton Therapy for Patients With Mediastinal Hodgkin Lymphoma.
Mailhot Vega RB; Mohammadi H; Patel SI; Holtzman AL; Lockney NA; Lynch JW; Bansal MM; Liang X; Slayton WB; Parsons SK; Hoppe BS; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2022 Jan; 112(1):158-166. PubMed ID: 34348176
[TBL] [Abstract][Full Text] [Related]
4. Recent Time Trends and Predictors of Heart Dose From Breast Radiation Therapy in a Large Quality Consortium of Radiation Oncology Practices.
Pierce LJ; Feng M; Griffith KA; Jagsi R; Boike T; Dryden D; Gustafson GS; Benedetti L; Matuszak MM; Nurushev TS; Haywood J; Radawski JD; Speers C; Walker EM; Hayman JA; Moran JM;
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1154-1161. PubMed ID: 28927756
[TBL] [Abstract][Full Text] [Related]
5. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
6. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.
Bradley JA; Dagan R; Ho MW; Rutenberg M; Morris CG; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):411-421. PubMed ID: 26611875
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
8. Model-based approach for quantitative estimates of skin, heart, and lung toxicity risk for left-side photon and proton irradiation after breast-conserving surgery.
Tommasino F; Durante M; D'Avino V; Liuzzi R; Conson M; Farace P; Palma G; Schwarz M; Cella L; Pacelli R
Acta Oncol; 2017 May; 56(5):730-736. PubMed ID: 28281862
[TBL] [Abstract][Full Text] [Related]
9. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.
Mailhot Vega R; Kim J; Hollander A; Hattangadi-Gluth J; Michalski J; Tarbell NJ; Yock TI; Bussiere M; MacDonald SM
Cancer; 2015 May; 121(10):1694-702. PubMed ID: 25641407
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Tishler RB; Pham NL; Punglia RS
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
[TBL] [Abstract][Full Text] [Related]
12. Cost-Effectiveness of Proton Versus Photon Therapy in Pediatric Medulloblastoma Treatment: A Patient Volume-Based Analysis.
Fernandes RRA; Vianna CMM; Guerra RL; Cancela MC; Almeida LM; Pereira AJDC; Viégas CMP; Ferman SE; Corrêa F
Value Health Reg Issues; 2019 Dec; 20():122-128. PubMed ID: 31319299
[TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.
Mailhot Vega RB; Kim J; Bussière M; Hattangadi J; Hollander A; Michalski J; Tarbell NJ; Yock T; MacDonald SM
Cancer; 2013 Dec; 119(24):4299-307. PubMed ID: 24105630
[TBL] [Abstract][Full Text] [Related]
14. Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.
Flejmer AM; Edvardsson A; Dohlmar F; Josefsson D; Nilsson M; Witt Nyström P; Dasu A
Acta Oncol; 2016 May; 55(5):577-83. PubMed ID: 27027913
[TBL] [Abstract][Full Text] [Related]
15. Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
Prasanna PG; Rawojc K; Guha C; Buchsbaum JC; Miszczyk JU; Coleman CN
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1325-1340. PubMed ID: 33640423
[TBL] [Abstract][Full Text] [Related]
16. Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer.
Cuaron JJ; Chon B; Tsai H; Goenka A; DeBlois D; Ho A; Powell S; Hug E; Cahlon O
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):284-91. PubMed ID: 25754632
[TBL] [Abstract][Full Text] [Related]
17. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
Lomax AJ; Cella L; Weber D; Kurtz JM; Miralbell R
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):785-92. PubMed ID: 12573766
[TBL] [Abstract][Full Text] [Related]
18. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer.
Brodin NP; Kabarriti R; Schechter CB; Pankuch M; Gondi V; Kalnicki S; Garg MK; Tomé WA
Radiat Oncol; 2021 Jan; 16(1):19. PubMed ID: 33478544
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of raloxifene and hormone replacement therapy in postmenopausal women: impact of breast cancer risk.
Armstrong K; Chen TM; Albert D; Randall TC; Schwartz JS
Obstet Gynecol; 2001 Dec; 98(6):996-1003. PubMed ID: 11755544
[TBL] [Abstract][Full Text] [Related]
20. Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German setting.
Blohmer JU; Rezai M; Kümmel S; Kühn T; Warm M; Friedrichs K; Benkow A; Valentine WJ; Eiermann W
J Med Econ; 2013; 16(1):30-40. PubMed ID: 22966753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
